13F Holdings
中文EN

SIBN SI-BONE, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1459839 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY14.0%
TTM net income YoY37.1%
TTM EPS YoY39.2%
Revenue 3-yr CAGR18.7%
Net income 3-yr CAGR—

Margins

Gross margin79.4%
Operating margin-7.6%
Net margin-6.2%
FCF margin-1.9%
EBITDA margin-4.6%

Returns

ROE-7.7%
ROA-5.6%
ROIC (approx.)-7.2%
Asset turnover0.90x

Leverage & solvency

Liabilities / assets28.1%
Debt / equity0.19x
Current ratio7.58x
Interest coverage-6.88x

Cash quality & payout

Operating cash flow / net income-0.44x
Accruals ratio-8.1%
Payout ratio—
Capex / revenue4.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$200.93M$167.18M$138.89M$106.41M$90.15M
Cost of revenue$41.05M$35.06M$29.47M$15.71M$10.43M
Gross profit$159.88M$132.12M$109.42M$90.70M$79.72M
R&D expense$17.45M$16.56M$15.03M$13.63M$12.44M
SG&A expense$40.54M$33.76M$31.07M$28.96M$25.07M
Operating income-$22.33M-$35.25M-$46.93M-$59.61M-$51.67M
Interest expense$2.63M$3.44M$3.46M$2.82M$5.37M
Pretax income-$19.09M-$31.08M-$43.49M-$61.40M-$57.03M
Income tax$0$0$0$0$0
Net income-$18.90M-$30.91M-$43.34M-$61.26M-$56.57M
EBITDA-$16.56M-$30.87M-$41.50M-$56.16M-$49.58M
EPS (basic)-0.44-0.75-1.13-1.79-1.71
EPS (diluted)-0.44-0.75-1.13-1.79-1.71
Dividends declared per share0.000.000.000.000.00
Weighted avg. shares (diluted)42.96M41.47M38.43M34.20M33.15M
Balance sheet
Cash & equivalents$42.24M$34.95M$33.27M$20.72M$63.42M
Short-term investments———$76.57M$83.56M
Receivables$29.91M$27.46M$21.95M$20.67M$14.25M
Inventory$33.90M$27.07M$20.25M$17.28M$11.50M
Current assets$216.12M$207.78M$211.39M$137.61M$175.87M
PP&E, net$21.30M$20.37M$16.00M$15.56M$8.99M
Total assets$238.56M$230.44M$230.43M$157.55M$190.51M
Current liabilities$25.28M$27.13M$23.46M$21.18M$16.89M
Short-term debt————$0
Long-term debt$35.57M$35.45M$36.06M$35.17M$34.97M
Total debt$35.57M$35.45M$36.06M$35.17M$34.97M
Total liabilities$61.02M$63.47M$61.05M$59.25M$56.09M
Shareholders' equity$177.53M$166.96M$169.38M$98.30M$134.42M
Net debt-$6.67M$504,000$2.79M$14.45M-$28.45M
Shares outstanding43.65M42.09M40.69M34.73M33.67M
Cash flow statement
Operating cash flow-$675,000-$12.43M-$18.71M-$41.66M-$39.53M
Capital expenditure$8.41M$10.50M$7.80M$9.51M$6.39M
Free cash flow-$9.09M-$22.92M-$26.51M-$51.16M-$45.92M
Investing cash flow$4.16M$12.62M-$59.80M-$2.81M$51.58M
Financing cash flow$3.38M$1.96M$90.93M$2.20M-$1.71M
Depreciation & amortization$5.77M$4.38M$5.43M$3.45M$2.09M
Stock-based compensation$25.52M$25.87M$24.06M$23.06M$16.87M

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.